Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/dkq002 ◽

2010 ◽

Vol 65 (4) ◽

pp. 735-740 ◽

Author(s):

L. Milazzo ◽

I. Caramma ◽

C. Mazzali ◽

M. Cesari ◽

M. Olivetti ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Pegylated Interferon ◽

Randomized Controlled Study ◽

Controlled Study ◽

Virus Genotype ◽

Randomized Controlled

Download Full-text

Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study

Hepatology Research ◽

10.1111/hepr.12938 ◽

2017 ◽

Vol 48 (3) ◽

pp. E146-E154 ◽

Author(s):

Goki Suda ◽

Jun Ito ◽

Atsushi Nagasaka ◽

Yoshiya Yamamoto ◽

Ken Furuya ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Combination Therapy ◽

Pegylated Interferon ◽

Randomized Controlled Study ◽

Controlled Study ◽

Hepatitis C Virus Infection ◽

Randomized Controlled

Download Full-text

An open-label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin

Journal of Viral Hepatitis ◽

10.1111/j.1365-2893.2011.01584.x ◽

2012 ◽

Vol 19 (9) ◽

pp. 615-622 ◽

Author(s):

C. Kondo ◽

M. Atsukawa ◽

A. Tsubota ◽

N. Itokawa ◽

T. Fukuda ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Randomized Controlled Study ◽

Controlled Study ◽

Randomized Controlled

Download Full-text

A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3

SpringerPlus ◽

10.1186/s40064-016-2920-z ◽

2016 ◽

Vol 5 (1) ◽

Author(s):

Graham R. Foster ◽

Kazuaki Chayama ◽

Wan-Long Chuang ◽

Hugo Fainboim ◽

Martti Farkkila ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Randomized Controlled Study ◽

Controlled Study ◽

Virus Genotype ◽

Randomized Controlled ◽

Download Full-text

Faculty of 1000 evaluation for Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718020710.793480337 ◽

2013 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Phase 2 ◽

Virus Genotype ◽

Double Blind ◽

Phase 2 Trial ◽

Pegylated Interferon Alfa

Download Full-text

Faculty Opinions recommendation of Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718196356.793490906 ◽

2014 ◽

Author(s):

Arthur Kim

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Randomized Trial ◽

Low Dose ◽

Pegylated Interferon ◽

Virus Genotype ◽

Interferon Α2a ◽

Treatment Naïve

Download Full-text

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial

10.1016/s0140-6736(14)61795-5 ◽

2015 ◽

Vol 385 (9973) ◽

pp. 1075-1086 ◽

Author(s):

Eric Lawitz ◽

Edward Gane ◽

Brian Pearlman ◽

Edward Tam ◽

Wayne Ghesquiere ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Phase 2 ◽

Efficacy And Safety ◽

Virus Genotype ◽

Phase 2 Trial ◽

Open Label Phase ◽

Download Full-text

Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial

10.1016/s0140-6736(14)61793-1 ◽

2015 ◽

Vol 385 (9973) ◽

pp. 1087-1097 ◽

Author(s):

Mark Sulkowski ◽

Christophe Hezode ◽

Jan Gerstoft ◽

John M Vierling ◽

Josep Mallolas ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Phase 2 ◽

Efficacy And Safety ◽

Virus Genotype ◽

Phase 2 Trial ◽

Open Label Phase

Download Full-text

A Double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK2336805 when given as monotherapy and in combination with peginterferon alfa-2a and ribavirin in hepatitis C virus genotype 1-infected

Liver International ◽

10.1111/liv.12334 ◽

2013 ◽

Vol 34 (6) ◽

pp. e89-e95 ◽

Author(s):

Stephen Gardner ◽

Amy Cutrell ◽

Cindy Elko-Simms ◽

Kimberly Adkison ◽

Robert Hamatake ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Antiviral Activity ◽

Controlled Study ◽

Virus Genotype ◽

Double Blind ◽

Peginterferon Alfa

Download Full-text

235 SAPPHIRE II: Phase 3 Placebo-Controlled Study of Interferon-Free, 12-Week Regimen of ABT-450/r/ABT-267, ABT-333, and Ribavirin in 394 Treatment-Experienced Adults With Hepatitis C Virus Genotype 1

Gastroenterology ◽

10.1016/s0016-5085(14)63286-8 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-904

Author(s):

Ira M. Jacobson ◽

Stefan Zeuzem ◽

Tolga Baykal ◽

Rui T. Marinho ◽

Fred Poordad ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Controlled Study ◽

Virus Genotype ◽

Download Full-text

Long-term Pegylated Interferon Monotherapy Following 72 Weeks of Pegylated Interferon and Ribavirin in Hepatitis C Virus Genotype-1-infected Slow Responders

Internal Medicine ◽

10.2169/internalmedicine.54.2718 ◽

2015 ◽

Vol 54 (3) ◽

pp. 273-279 ◽

Author(s):

Shinya Watanabe ◽

Yoshimasa Kobayashi ◽

Kazuhito Kawata ◽

Hidenao Noritake ◽

Takeshi Chida ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Pegylated Interferon ◽

Virus Genotype ◽

Interferon Monotherapy

Download Full-text